Drug Trials Snapshots: IMDELLTRA (tarlatamab/dlle)

Drug Trials Snapshots: IMDELLTRA (tarlatamab/dlle) IMDELLTRA is a drug approved for the treatment of adult patients with extensive stage small cell lung cancer (ES-SCLC), whose cancer has progressed after prior treatment with chemotherapy that contains platinum. https://www.fda.gov/drugs/development-approval-process-drugs/drug-trials-snapshots-imdelltra